Hi Tony,
From my perspective, you've continued to tick boxes in order, one after the other, giving PLV a better than even chance of success in what is a pretty difficult (that's a mild understatement) business environment.
A few questions:
1) Are you able to clearly articulate what additional boxes need to be ticked and in what timeframe/s to ensure we are producing in Cockatoo (early 2013?) & Irvine (2014?)
2) I'd also like your personal comments on the challenges of working with our chinese partners. I'm sure it's not as simple as "they missed another deadline - doom&gloom" when it comes to engaging and doing business?
3) Finally, I rec'd my multiple copies in the mail of the Independent Experts Report and Proxy Forms etc.....surely there has to be a better and more effective of getting these documents through to shareholders?? - thats a comment not a question - wonderful bedtime reading :-)
I look forward to meeting you at the shareholder meeting on 29/6.
Cheers,
Snagger
- Forums
- ASX - By Stock
- PLV
- questions 1st june 2012
questions 1st june 2012, page-19
-
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online